EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolomic Insights into Smoking-Induced Metabolic Dysfunctions: A Comprehensive Analysis of Lipid and Amino Acid Metabolomes

Muhammad Amtiaz Aslam, Hajra Iqbal, Kainat Ilyas, Kanwal Rehman iD, Amjad Hussain iD, Muhammad Sajid Hamid Akash iD, Mudassar Shahid iD, Shuqing Chen iD

Metabolites · 04.02.2025 · 15 (2) · 96

DOI: 10.3390/metabo15020096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Metabolites, online erschienen am 04.02.2025. Verfasst von Muhammad Amtiaz Aslam und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Government College University, Faisalabad 38000, Pakistan. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Saud University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cigarette smoking is a leading cause of preventable mortality, largely due to the absence of effective, non-invasive biomarkers for early disease detection. Profiling serum metabolomics to identify metabolic changes holds the potential to accelerate the detection process and identify individuals at risk of developing smoking-related diseases.

Objectives

This study investigated the biochemical and metabolomic changes induced by nicotine exposure, with a focus on disruptions in amino acid, lipid, and carbohydrate metabolism.

Methods

Liquid chromatography–tandem mass spectrometry (LC-MS/MS) was employed to observe significant disruptions in lipid and amino acid metabolism, along with alterations in key metabolic pathways. A total of 400 smokers and 100 non-smokers were included to evaluate the biomarkers related to insulin resistance, blood lipid profile, inflammation, and kidney and liver function.

Results

The results demonstrated significantly elevated (p < 0.05) levels of glycemic markers in smokers, including fasting blood glucose; glycated hemoglobin (HbA1c); and inflammatory markers such as interleukin-6 (IL-6) and C-reactive protein (CRP). Smokers also exhibited dyslipidemia, with increased total cholesterol (154.888 ± 35.565) and LDL levels (117.545 ± 24.138). Impaired liver and kidney function was evident, with significantly higher levels (p < 0.05) of AST, ALP, ALT, blood urea nitrogen, and creatinine in smokers. A total of 930 metabolites were identified, of which 343 exhibited significant alterations (p < 0.05) in smokers compared to non-smokers. Among these, 116 metabolites were upregulated, and 127 were downregulated. Metabolomic pathway analysis revealed eight significant pathways. The study also identified three lipid metabolites specific to smokers and seven unique to non-smokers. Through LC-MS/MS, fragments of phenylalanine, tryptophan, valine, histidine, carnitine, and sphinganine were detected. Several lipidomic changes associated with insulin resistance and cardiovascular complications were observed. Cadmium (Cd) levels were higher in smokers than non-smokers (1.264 ppb vs. 0.624 ppb) and showed a strong negative correlation (R2 = 0.8061, p-value = 0.015) with serum zinc (Zn), likely due to Cd displacing Zn in proteins and causing nephrotoxicity through accumulation.

Conclusions

This study highlights the distinct metabolic disruptions caused by smoking that could serve as potential biomarkers for the early detection of metabolic diseases. It emphasizes the importance of metabolomics in identifying systemic indicators of smoking-related health issues, providing new opportunities for preventive and therapeutic interventions.

Schlagwörter

Stichwörter der Autor:innen

amino acid profilinglipid metabolismmetabolomic analysisnicotine exposureoxidative stress

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Government College University, Faisalabad 38000, Pakistan.
  • Department of Pharmacy, The Women University, Multan 60000, Pakistan.
  • Department of Chemistry, University of Okara, Okara 56300, Pakistan.
  • Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
  • Institute of Drug Metabolism and Drug Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.

ORCID-Profile: Kanwal Rehman, Amjad Hussain, Muhammad Sajid Hamid Akash, Mudassar Shahid, Shuqing Chen

Förderung

  • King Saud University

Zitieren

APA

Aslam, M. A., Iqbal, H., Ilyas, K., Rehman, K., Hussain, A., Akash, M. S. H., Shahid, M., & Chen, S. (2025). Metabolomic Insights into Smoking-Induced Metabolic Dysfunctions: A Comprehensive Analysis of Lipid and Amino Acid Metabolomes. Metabolites, 15(2), 96. https://doi.org/10.3390/metabo15020096

Vancouver

Aslam MA, Iqbal H, Ilyas K, Rehman K, Hussain A, Akash MSH, et al. Metabolomic Insights into Smoking-Induced Metabolic Dysfunctions: A Comprehensive Analysis of Lipid and Amino Acid Metabolomes. Metabolites. 2025;15(2):96. doi:10.3390/metabo15020096

BibTeX
@article{Aslam2025,
  author = {Aslam, Muhammad Amtiaz and Iqbal, Hajra and Ilyas, Kainat and Rehman, Kanwal and Hussain, Amjad and Akash, Muhammad Sajid Hamid and Shahid, Mudassar and Chen, Shuqing},
  title = {Metabolomic Insights into Smoking-Induced Metabolic Dysfunctions: A Comprehensive Analysis of Lipid and Amino Acid Metabolomes},
  journal = {Metabolites},
  year = {2025},
  volume = {15},
  number = {2},
  pages = {96},
  doi = {10.3390/metabo15020096}
}
Kostenlos starten →